Ptc Therapeutics, Inc. · NASDAQ:PTCT
The Vanguard Group reported a 10.43% stake in Ptc Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 30, 2025
The Vanguard Group reported a 10.43% stake in Ptc Therapeutics, Inc., 8,288,999 shares, as a passive investor on Sep 30, 2025. Filed Oct 30, 2025 (Schedule 13G/A).
- Stake
- 10.43%
- Shares
- 8,288,999
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 10.43% | 8,288,999 |
Source
Related
- Ptc Therapeutics, Inc.
- The Vanguard Group
- Ptc Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Form 4 · Schmertzler Michael · Oct 16, 2026
- Form 4 · Boulding Mark Elliott · Oct 13, 2026
- Form 4 · Schmertzler Michael · Oct 9, 2026
- Form 4 · Boulding Mark Elliott · Oct 7, 2026
- Form 4 · Steele Glenn Jr Md Phd · Oct 2, 2026